You have to feel sorry for some of the shareholders on this message board. It would be nice if Martin would throw them a bone every so often.
"a buyout just when the company shows promise would strike me as killing the goose that lays the golden eggs."
This goose is clearly laying something, but you have mistaken golden eggs for golden turds.
The short sellers must be quivering in their boots. Just think. If the stock continues to rise, then maybe, just maybe it will be worth 50% of the value in February. Martin Gerstal just exudes confidence in the investment community.
I'm not bashing the company. Martin Gerstal needs no help. He is your worst enemy, and not the few short sellers in the stock.
Both the dogs are putting in new lows on the same day. The market cap for CGEN was higher in February than the market cap of both companies combined today. Shareholders can credit Martin Gerstal and his bungled secondary offering for much of the problem.
"I am afraid what Anat will say on thursday is controlled by MG"
You make it sound like this is a Russian company rather than an Israeli company, but there is some truth in what you say. The stock has dropped from $14 to $6 yet Gerstal is pleased with everything. The drop from $8 can certainly be attributed to the "Gerstal factor".
I'm waiting to buy. $6.55 is too rich for my blood. You have to discount for the Gerstal factor. Have you ever seen a company realign their business strategy as many times in one year as this company does on a regular basis? They have decided now that they will bundle molecules and only sell in a package deal? What a novel idea! It took them an entire year to figure out this new strategy? Why haven't they sold a bundled package by now?
How difficult would it be to sell Compugen without including Evogene in some package deal?
The only member of Martin's Israeli Dream Team who knew anything about making money was sweet, little Dikla, and she is long gone. What a shame. Dikla sure knew how to turn a dollar.
They had promised a new partnership deal, and when it didn't happen, this management team was too arrogant to tell you why not. They thought they would spare you the specifics for your own good, and simply tell you they are maximizing shareholder value. I'm not sure who the financial gurus are at this company, but $14 to $6 hardly looks like maximizing anything but losses to me. Who was the deal supposed to be with? Why did it fall through? They are going after a package deal now? Sounds great! Why haven't they delivered"?